Misleading

"Burger King Ads Under Fire: Judge Allows Lawsuit Over Misleading Whopper Sizes to Proceed"

by

Miami, Fla. — A federal judge has determined that Burger King may be held accountable for how it portrays its Whopper in advertisements, as the fast-food chain faces a lawsuit alleging that it misrepresents the burger’s size. The ruling allows a group of customers, who claim that the burgers served do not match the size depicted in ads, to continue their legal challenge against the company. Judge Roy Altman denied Burger King’s request to dismiss the case, which began when Anthony Russo, a Florida lawyer, filed a lawsuit on behalf of dissatisfied customers. They argue … Read more

Jury Awards $2.3 Million in ‘Made in USA’ Label Dispute: Bigelow Tea Faces Legal Repercussions Over Misleading Packaging Claims

by

A recent jury decision in the Banks v. R.C. Bigelow, Inc. case has stirred discussions about national origin marketing claims, as the tea manufacturer was fined $2.3 million. The litigation centered on the validity of Bigelow’s “Manufactured in the USA 100%” labels, which plaintiffs contended were misleading since the raw tea was imported. The company argued that the designation referred only to the blending and packaging processes, which occur in the United States. The court had earlier ruled that the claim was indeed false, leaving the jury to decide on the extent of the damages … Read more

Investigation Launched into Ibotta, Inc. for Alleged Misleading Financial Disclosures; Shareholders Might Be Compensated

by

New York, NY — The internationally recognized investor rights law firm, Rosen Law Firm, is currently investigating potential securities claims on behalf of shareholders of Ibotta, Inc. (NYSE: IBTA). This investigation follows allegations that Ibotta might have provided the investing public with significantly misleading business information. Shareholders who purchased securities in Ibotta could potentially receive compensation through a contingency fee arrangement, meaning they would not face any out-of-pocket fees or costs. Rosen Law Firm is in the process of assembling a class action lawsuit to pursue recovery of investor losses. To become a member of … Read more

Johnson & Johnson Subsidiary Fined $1.64 Billion Over Misleading HIV Drug Promotions

by

Philadelphia, PA – A U.S. jury has ruled against a Johnson & Johnson subsidiary, ordering the pharmaceutical giant to pay $1.64 billion in a landmark case that accuses the company of misleading marketing practices related to its HIV treatments. This verdict marks one of the largest in a series of legal challenges faced by the company. The case revolved around the allegations that Janssen Pharmaceuticals, a unit of Johnson & Johnson, engaged in false and misleading promotion of its drugs used to treat HIV. The lawsuit claimed that the company failed to adequately warn patients … Read more